Invizius – the Edinburgh-based BioTech company developing breakthrough treatments for patients on dialysis – has raised £950,000. The funding round was led by Mercia Ventures and supported by Calculus Capital, Syensqo, the University of Edinburgh’s Old College Capital and Scottish Enterprise. The latest investment will enable the company to prepare for the next stage of … Continue reading ‘Dialysis breakthrough’ BioTech raises further funds